Research programme: sodium glucose co-transporter inhibitors - Taisho

Drug Profile

Research programme: sodium glucose co-transporter inhibitors - Taisho

Alternative Names: SGLT inhibitors - Taisho

Latest Information Update: 23 Sep 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Taisho Pharmaceutical
  • Class Small molecules
  • Mechanism of Action Sodium-glucose transport protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Type 2 diabetes mellitus

Most Recent Events

  • 25 Jul 2007 Preclinical development is ongoing
  • 01 Nov 2005 Data presented at the 41st Annual Meeting of the European Association for the Study of Diabetes (EASD-2005) has been added to the Diabetes pharmacodynamics section
  • 06 Jul 2005 Preclinical trials in Type-2 diabetes mellitus in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top